Consider the Role of Ongentys and Kynmobi for Parkinson’s Disease
Ongentys (opicapone) and Kynmobi (apomorphine) will add to the growing list of new meds for Parkinson’s disease.
They’re for “off” episodes...when symptoms (tremor, etc) return between carbidopa/levodopa doses, especially as Parkinson’s progresses.
Optimize carbidopa/levodopa first...such as with more frequent dosing. Put the role of the new meds in perspective.